Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Meta-Analysis and Systematic Review
- PMID: 30481628
- DOI: 10.1016/j.wneu.2018.11.167
Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Meta-Analysis and Systematic Review
Abstract
Background: Chronic subdural hematoma is a very common neurosurgical condition. Although conventional surgical methods, such as burr hole irrigation, have been the mainstay of treatment, middle meningeal artery (MMA) embolization has emerged as a promising adjunctive or alternative treatment. The aim of this article was to present a meta-analysis and systematic review of this topic.
Methods: A literature search using keywords "chronic subdural hematoma," "chronic subdural hemorrhage," "refractory subdural hematoma," "refractory subdural hemorrhage," and "middle meningeal artery embolization" was conducted through October 2018. Outcome variables of hematoma recurrence, surgical complications, and modified Rankin Scale score were analyzed and compared between MMA embolization and conventional surgery cohorts.
Results: Three double-arm studies comparing embolization and conventional surgery groups and 6 single-arm case series were identified and analyzed. Hematoma recurrence rate was significantly lower in the embolization group compared with conventional treatment group (2.1% vs. 27.7%; odds ratio = 0.087; 95% confidence interval, 0.026-0.292; P < 0.001; I2 = 0%); surgical complication rates were similar between groups (2.1% vs. 4.4%; odds ratio = 0.563; 95% confidence interval, 0.107-2.96; P = 0.497; I2 = 27.5%). Number of patients with modified Rankin Scale score >2 in the embolization (12.5%) versus conventional treatment (9.1%) group showed no statistical difference (P = 0.689). A composite hematoma recurrence rate of 3.6% was found after summing the 6 case series. Composite recurrence and complication rates in the embolization cohorts of the double-arm studies and the case series were lower than literature values for conventional surgical treatments.
Conclusions: MMA embolization is a promising treatment for chronic subdural hematoma. Future randomized clinical trials are needed.
Keywords: Chronic subdural hematoma; Chronic subdural hemorrhage; Middle meningeal artery embolization; Refractory subdural hematoma; Refractory subdural hemorrhage.
Copyright © 2018 Elsevier Inc. All rights reserved.
Comment in
-
Letter to the Editor Regarding: "Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Meta-Analysis and Systematic Review".World Neurosurg. 2019 Apr;124:480-481. doi: 10.1016/j.wneu.2018.12.138. World Neurosurg. 2019. PMID: 31287060 No abstract available.
Similar articles
-
Midterm Follow-Up of Patients with Middle Meningeal Artery Embolization in Intractable Chronic Subdural Hematoma.World Neurosurg. 2019 Jun;126:e671-e678. doi: 10.1016/j.wneu.2019.02.121. Epub 2019 Mar 4. World Neurosurg. 2019. PMID: 30844521
-
Enhanced Hematoma Membrane on DynaCT Images During Middle Meningeal Artery Embolization for Persistently Recurrent Chronic Subdural Hematoma.World Neurosurg. 2019 Jun;126:e473-e479. doi: 10.1016/j.wneu.2019.02.074. Epub 2019 Feb 28. World Neurosurg. 2019. PMID: 30825631
-
Efficacy and mid-term outcome of middle meningeal artery embolization with or without burr hole evacuation for chronic subdural hematoma compared with burr hole evacuation alone.J Neurointerv Surg. 2022 Mar;14(3):297-300. doi: 10.1136/neurintsurg-2021-017450. Epub 2021 Jun 29. J Neurointerv Surg. 2022. PMID: 34187870
-
Embolization of the middle meningeal artery in patients with chronic subdural hematoma-a systematic review and meta-analysis.Acta Neurochir (Wien). 2020 Apr;162(4):777-784. doi: 10.1007/s00701-020-04266-0. Epub 2020 Feb 21. Acta Neurochir (Wien). 2020. PMID: 32086603
-
Which surgical procedure is effective for refractory chronic subdural hematoma? Analysis of our surgical procedures and literature review.J Clin Neurosci. 2018 Mar;49:40-47. doi: 10.1016/j.jocn.2017.11.009. Epub 2017 Dec 20. J Clin Neurosci. 2018. PMID: 29274740 Review.
Cited by
-
The Use of Middle Meningeal Artery Embolization to Treat Chronic Subdural Hematoma in the Pediatric Population: A Review of the Literature.Cureus. 2024 Jun 7;16(6):e61874. doi: 10.7759/cureus.61874. eCollection 2024 Jun. Cureus. 2024. PMID: 38978883 Free PMC article. Review.
-
Radiologic Evaluation Criteria for Chronic Subdural Hematomas: Recommendations for Clinical Trials.AJNR Am J Neuroradiol. 2022 Nov;43(11):1550-1558. doi: 10.3174/ajnr.A7503. Epub 2022 May 26. AJNR Am J Neuroradiol. 2022. PMID: 35618427 Free PMC article. Review.
-
High frequency of ophthalmic origin of the middle meningeal artery in chronic subdural hematoma.Neuroradiology. 2020 May;62(5):639-644. doi: 10.1007/s00234-020-02363-6. Epub 2020 Jan 21. Neuroradiology. 2020. PMID: 31965212
-
Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A National Database Study of 191 Patients in the United States.World Neurosurg. 2021 Sep;153:e300-e307. doi: 10.1016/j.wneu.2021.06.101. Epub 2021 Jun 29. World Neurosurg. 2021. PMID: 34214657 Free PMC article.
-
Middle meningeal artery embolization for symptomatic chronic subdural hematoma in the setting of severe transfusion-refractory thrombocytopenia: A case study and review of literature.Surg Neurol Int. 2023 Jun 30;14:223. doi: 10.25259/SNI_1051_2022. eCollection 2023. Surg Neurol Int. 2023. PMID: 37404508 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical